InteliCare's benefit from the Budget's aged care funding boost
About this video
Key takeaways:
The federal budget's investment in aged care and health sectors translates into benefits for InteliCare.
AI plays a significant role in InteliCare's services, featuring in preventive care and rapid response during medical emergencies.
InteliCare is considering global expansion after establishing a strong presence in Australia.
Daniel Pilbrow, CEO of InteliCare, describes the positive impact of the federal budget's $2.2 billion investment into aged care on his company. InteliCare, an aged care software service, benefits significantly from the provision of 24,000 new home care places. Daniel emphasises that the influx of funds into the aged care and health sectors not only enhance care quality but also yield benefits for companies like InteliCare that strive to meet the increasing budget requirements.
In discussing the services rendered by InteliCare, Daniel highlights how the company began as an AI platform for supporting people to live independently. Its services have since expanded into a variety of sectors, including the residential aged care sector, disability accommodation space, and the home patient support sector. He asserts the importance of AI in preventing illnesses and swiftly providing help to those who become ill, thereby aiding in effective home management and alleviating burden on hospital facilities.
Daniel also contemplates the issue of AI-related fear among people and cybercrime worries. He reassures that InteliCare maintains rigid standards for privacy and only collects necessary data relating to care and related activities. Pointing to the emerging importance of technology in healthcare, he hints at the potential for the company to leverage the growing demand for data informed care, which is crucial for early detection of health decline. By consolidating the company's presence in Australia, Daniel sees enormous global expansion opportunities, specifically in Southeast Asia, the Middle East, and Northern hemisphere.
Find the full unedited transcript of this interview below:
In the federal budget's $2.2 billion injection into aged care provisions, in particular, the provision of 24,000 new home care places, which could be a beneficiary to some small cap companies. And that includes the aged care software as a service company InteliCare. The CEO of InteliCare, Daniel Pilbrow, joins me now. Daniel, thank you so much for coming in. Nice to see you. So how did you watch the budget? Were you cheering there at Jim Chalmers? Absolutely, absolutely. Any time the government puts additional funding into the aged care and health care sectors is great for the sector, and it's great for the people who are receiving care. So and then there's a benefit for for a flow on benefit to companies like ours that we can do, we can help the sector don't respond to those budget requirements. So tell us what you do in InteliCare because you've expanded a little bit, but you started as sort of like a digital provider. Yeah, we started as effectively an AI platform to support people to live independently in their own home. As they got older and so largely worked within the aged care home, home based care market, particularly with home care package clients. We've more more recently
0:59
broadened into the residential aged care sector, got a number of clients in that space and also in the support of disability accommodation space and also into the hospital at home support. So remote patient monitoring using our platform in a variety of ways to to really help the sector respond to the changing environments that are there. How important is the use of AI in, I guess, prevention or ensuring that if somebody does fall ill, we can get help to them as soon as possible? Look really important? I think the more important as time goes on, even more important, the fact is the cost of care in hospital based environments is very expensive and the government's clearly recognised that. And the clear focus is how do we manage people more effectively at home, both in the home care aged care sector? But also you're seeing that with models of care within the hospital sector of really focusing on how do we help people in the hospital, in the home environment. So products like ours, AI driven platforms that actually understand how someone's going in their home environment really feed in well to supporting those sort of government aims.
1:59
So tell us how you sort of go about your business. Do you just go and have meetings with aged care homes or how does this. So we have a variety of contact points to aged care providers, be they residential or home based care. And there's a lot of providers who are both and also retirement living providers. So they might do the full gamut of that whole sort of spectrum. And we're just yeah, we're out there talking to as many providers as we can to have them understand how we might be able to help them solve their challenges. So with, as we mentioned, some of the budget relief that is going to come through into the space, how helpful is that going to be for InteliCare? And what would you like to see done even further to expand, I guess help for aged care providers? Well, I think there's two really big components in the budget, the 2.2 billion towards aged care. I mean, there's 534,534 million to home care packages, an extra 24,000 home care packages. That's fantastic for the sector because there's a lot of people waiting for the level of care that they require. And I think the sentiment nowadays in our environment is to have people
2:59
being cared for at home, rather than requiring high levels of care in a, in a in a residential aged care setting. And that's clearly the government focus. So more funding towards supporting keeping people at home is fantastic. The other thing that was really great to see was the 1.2 billion they put into the Strengthening Medicare program, of which 610 million went towards states and territories to support the older patients who might be in hospitals. How do we help them get back into their home environment more effectively? And an extra hundred and $90 million towards strengthening the transition care program, which is focused on older Australians who've just had a hospital stay. So there's there's money there to support the care providers, to support people being in the environment they want to be. And a product like ours really has a long part to play in supporting the sector to achieve that. I just had a fascinating conversation about AI more broadly within financial markets, but the person I was interviewing was saying, there's so much fear in this space. How do you sort of
3:59
reconcile with people that might be fearful of AI or I guess, even concerns about cybercrime? Yeah. Look, I think we've our platform has been validated against the Australian privacy privacy principles being independently audited. So we're pretty we're pretty confident that we're safe. I think the key thing is about reassuring people about what data is actually being captured. Um, we're not capturing data about their personal details. It's more about the events that might relate to the care that they're undergoing or the the activities that they're undertaking. So I think the key thing there is it's just understanding what is being captured and what is being reported to the care provider that might be involved, and reassuring them that their personal information isn't going out there for someone else to to come and capture without their knowledge. You mentioned that you're happy with the budget. Are you happy in general, though, with the support of innovation in the healthcare sector in Australia? Absolutely. I think there's a real shift, I think post the Royal Commission or the Aged Care Royal Commission, that is and there's obviously been a Royal commission into the disability sector as
4:59
well. I think post, that there's been such a focus that that technology can play a big part, but just innovation in general in terms of the way that that care should be provided to the future. And I think my my view on that is that data informed care is the right way forward. If we can capture information to support care decision making, to optimize care, as you may, and you mentioned before about prevention, if we can understand when someone's deteriorating, before we see them deteriorating, then even better that we can actually help prevent something more significant occurring. Now, as we mentioned, your company could be one that could benefit from the budget. So investors watching our show would be watching that. I know you can't control the market, but I imagine that you would like to see your stock price higher than where it is. What do you think is fair value? Oh look, that's a fair value is but what the market is prepared to pay I mean if the key the key thing about that is, is care providers seeing the value in the technology and wanting to partner with us in, in solving the problems thereafter. And I think when we've got more traction in the market and we're
5:59
certainly on that pathway, we're working with some really great providers here in New South Wales and across the country at the moment. Um, that that's that confidence that we can send to the market, that our product is actually validated and actually making a difference in the way that care's delivered. I think that's the thing that determines the fair price. Do you have any plans to raise capital to do further research and development? Obviously, we're always focused on research development. That's one of the key focus and probably one of the values of our product, that we're constantly evolving and making it better and always looking to to the market to see what's best and partnering with those sorts of products and companies that we can. So absolutely, always looking to develop and yes, no, in any market scenario, we're always looking to our investors to how they can support us into the future. And I guess just also a question on on global expansion plans look fantastic opportunities for us globally. Yeah, I think the key thing for us is to really get a a strong presence and really consolidate here in Australia. But I think off that strong platform we can leverage into Southeast Asia and potentially the
6:58
Middle East and even over to the Northern hemisphere, maybe the US or maybe the UK and broader Europe. So there's there's enormous opportunity for products like ours and we see a great future for it.